Discovery
Strategic support for early-stage drug discovery programs, target identification, and lead optimization across multiple modalities.
Key Capabilities
- Target identification and validation strategies
- Lead compound identification and optimization
- Biologics discovery: antibodies, peptides, proteins
- Small molecule discovery program support
- Hit-to-lead and lead optimization guidance
- Structure-activity relationship (SAR) analysis
- Early ADME and safety profiling strategy
Our Approach
Successful drug discovery requires both scientific rigor and strategic vision. Bionavigen provides expert consulting to help clients identify and validate the most promising drug targets and develop high-quality lead compounds.
Our discovery consulting spans all major modalities — from small molecules to complex biologics including antibodies, bispecifics, peptides, and recombinant proteins. We help clients make the critical early decisions that set programs up for success.
We leverage our extensive industry network and knowledge of current pipeline trends to help clients identify differentiated opportunities and avoid common pitfalls in early drug discovery.